236 results on '"McGarrah, Robert W."'
Search Results
2. Association Between Lipoprotein(a) and Obstructive Coronary Artery Disease and High-Risk Plaque: Insights From the PROMISE Trial
3. Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial
4. BCAA-nitrogen flux in brown fat controls metabolic health independent of thermogenesis
5. Metabolomic profiling during ex situ normothermic perfusion before heart transplantation defines patterns of substrate utilization and correlates with markers of allograft injury
6. Branched-chain amino acids in cardiovascular disease
7. Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort study
8. Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients
9. A saturated map of common genetic variants associated with human height
10. Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs
11. Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach
12. BCAA catabolism in brown fat controls energy homeostasis through SLC25A44.
13. Abstract 16786: Integrative Omics in Failing Myocardium Highlights Metabolic Substrate Utilization Defects in Human Heart Failure
14. Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes
15. Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
16. Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street
17. Muscle-Liver Trafficking of BCAA-Derived Nitrogen Underlies Obesity-Related Glycine Depletion
18. Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations
19. Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction
20. Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk
21. Cardiac Rehabilitation: New Emphasis on Metabolic Disease
22. Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart
23. Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy
24. Trends in cardiorespiratory fitness: The evolution of exercise treadmill testing at a single Academic Medical Center from 1970 to 2012
25. Association of long-term PM2.5 exposure with traditional and novel lipid measures related to cardiovascular disease risk
26. Metabolomic profiling during ex situ normothermic perfusion before heart transplantation defines patterns of substrate utilization and correlates with markers of allograft injury
27. The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase
28. Effects of a 12-week mHealth program on peak VO2 and physical activity patterns after completing cardiac rehabilitation: A randomized controlled trial
29. Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes
30. Abstract 16981: Proteomic Profiles of Diabetic Heart Failure Report on Myocardial Metabolism, Ventricular Hypertrophy, and Endothelial Dysfunction
31. Abstract 15589: Mitochondrial Metabolites Predict Cardiovascular Outcomes and Heart Failure in People With Type 2 Diabetes Mellitus and Vascular Disease: A Tecos Substudy
32. Abstract 14727: Meteorin-like Glial Cell Differentiation Regulator is a Novel Protein Biomarker of Cardiovascular Outcomes in Patients With Diabetes and Vascular Disease: A TECOS Substudy
33. Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export
34. High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort
35. Metabolic Syndrome
36. Cardiac Rehabilitation: New Emphasis on Metabolic Disease
37. Confirmation of Statin and Fibrate Use from Small-Volume Archived Plasma Samples by High-Throughput LC-MS/MS Method
38. Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial
39. Integrative Omics: Harnessing the Proteome to Maximize the Potential of the Genome
40. The Effect of Vigorous- Versus Moderate-Intensity Aerobic Exercise on Insulin Action
41. Risk factors for cardiovascular disease among individuals with hepatic steatosis
42. Branched-chain amino acids in cardiovascular disease
43. Abstract 18498: Genome-wide Analysis Identifies Genetic Variants Associated With a Novel Inflammatory Cardiovascular Biomarker, GlycA
44. Abstract 18001: NMR Lipoprotein Profiling Identifies HDL Subclasses Associated With Obstructive CAD: Insights From the PROMISE Clinical Trial
45. Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity
46. Nervous system reduction in branched-chain amino acid metabolism disrupts hippocampal neurogenesis and memory
47. Bradykinin B1 and B2 Receptors Both Have Protective Roles in Renal Ischemia/Reperfusion Injury
48. Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure
49. Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
50. Abstract 9691: Lipoprotein Subclasses Are Associated With Hepatic Steatosis: Insights from the Prospective Multicenter Imaging Study for the Evaluation of Chest Pain (PROMISE) Clinical Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.